The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Self-citationRelationships between the structure of taxol analogs and their antimitotic activity
Gueritte-Voegelein, F., Guenard, D., Lavelle, F., Le Goff, M. T., Mangatal, L., & Potier, P. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a017 · Cited by 538
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Ying, X., Wen, H., Lu, W.-L., Du, J., Guo, J., Tian, W., Men, Y., Zhang, Y., Li, R.-J., Yang, T.-Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 447
Self-citationPardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z., Qian, Y., Sun, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.025 · Cited by 408
Self-citationZhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Self-citationPEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X.-R., Du, J., Ying, X., Lu, W.-L., Lou, J.-N., & Wei, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Self-citationSchlageter, K. E., Molnar, P., Lapin, G. D., & Groothuis, D. R. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2188 · Cited by 293
Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
Agarwal, S., Sane, R., Oberoi, R., Ohlfest, J. R., & Elmquist, W. F. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001888 · Cited by 292
Acquired multicellular-mediated resistance to alkylating agents in cancer.
Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., & Kerbel, R. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3294 · Cited by 278
Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26
Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264
Self-citationFang, J., Sawa, T., & Maeda, H. (2005) · Advances in Experimental Medicine and Biology · doi:10.1007/0-306-47932-x_2 · Cited by 221
Lu, W., Sun, Q., Wan, J., She, Z., & Jiang, X.-G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2354 · Cited by 219
Self-citationYan, H., Wang, L., Wang, J., Weng, X., Lei, H., Wang, X., Jiang, L., Zhu, J., Lu, W., Wei, X., et al. (2012) · ACS Nano · doi:10.1021/nn203749v · Cited by 191
Cell-Specific Aptamer-Mediated Targeted Drug Delivery
Zhou, J., & Rossi, J. J. (2011) · Oligonucleotides · doi:10.1089/oli.2010.0264 · Cited by 176
Du, J., Lü, W.-L., Ying, X., Liu, Y., Du, P., Tian, W. J., Men, Y., Guo, J., Zhang, Y., Li, R., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800218q · Cited by 160
Self-citationTeng, Y., Girvan, A. C., Casson, L. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4206 · Cited by 152
Vector-mediated drug delivery to the brain
Pardridge, W. M. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00087-8 · Cited by 146
Sun, X., Pang, Z., Ye, H., Qiu, B., Guo, L., Li, J., Ren, J., Qian, Y. J., Zhang, Q., Chen, J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.035 · Cited by 139
Self-citationWang, X., Duan, X., Yang, G., Zhang, X., Deng, L., Zheng, H., Deng, C., Wen, J., Wang, N., Peng, C. Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018490 · Cited by 138
Interleukin-13 receptor–targeted nanovesicles are a potential therapy for glioblastoma multiforme
Madhankumar, A. B., Slagle‐Webb, B., Mintz, A., Sheehan, J. M., & Connor, J. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0480 · Cited by 130
Huile, G., Pan, S., Yang, Z. H., Cao, S., Chen, C., Xin-guo, J., Shun, S., Zhiqing, P., & Yu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.069 · Cited by 117
Self-citationSerwer, L., & James, C. D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.004 · Cited by 117
Kim, S. Y., Lee, Y. M., Baik, D. J., & Kang, J. S. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00248-x · Cited by 116
Pang, Z., Gao, H., Yu, Y., Chen, J., Guo, L., Ren, J., Wen, Z., Su, J., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.063 · Cited by 82
Self-citationImaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier
Yan, H., Wang, J., Yi, P., Lei, H. C., Zhan, C., Xie, C., Feng, L., Qian, J., Zhu, J., Lu, W., et al. (2011) · Chemical Communications · doi:10.1039/c1cc12007g · Cited by 69
Self-citationAnti-glioma effect and safety of docetaxel-loaded nanoemulsion
Gao, H., Pang, Z., Pan, S., Cao, S., Yang, Z. H., Chen, C., & Jiang, X. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0214-8 · Cited by 61
Self-citationDonahue, M. J., Blakeley, J. O., Zhou, J., Pomper, M. G., Laterra, J., & van Zijl, P. C. M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21467 · Cited by 56
Jones‐Bolin, S., Zhao, H. Q., Hunter, K., Klein–Szanto, A. J., & Ruggeri, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0327 · Cited by 44
Sampath, P., Rhines, L. D., DiMeco, F., Tyler, B., Park, M. C., & Brem, H. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9159-4 · Cited by 33
Nagothu, K. K., Jaszewski, R., Moragoda, L., Rishi, A. K., Finkenauer, R., Tobi, M., Naumoff, J. A., Dhar, R., Ehrinpreis, M. N., Küçük, Ö., et al. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00100-4 · Cited by 24
Cited by
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Zhong, Y., Meng, F., Deng, C., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm5003009 · Cited by 541
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Grossen, P., Witzigmann, D., Sieber, S., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.028 · Cited by 496
Metadata
- Authors
- Gao, H., Qian, J., Cao, S., Yang, Z., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 33
- Issue
- 20
- Pages
- 5115-5123
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2070518196
- Cited by
- 280
- References
- 42
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.